Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 298 days ( -44.95 % )
Last Price $9,500.00 0 %
High/ Low $9,500.00 - $9,500.00 0%
Chg 7 Days N/A $9,500.00 $9,500.00
Chg 30 Days N/A $9,500.00 $9,500.00
Chg 12 mos 33.73 % $7,104.00 $9,500.00
Trend - 3 mos 0.264 % Width: 2.33 %
Trend - 12 mos 58.60 % Width: 25.99 %
Pred. range - 3 mos $9,323.68 - $9,541.07 -1.86 % - 0.432 %
Pred. range - 12 mos $14,500.49 - $18,269.06 52.64 % - 92.31 %
Short MA avg 3 mos Buy Oct 05, 2023 - 50 days
Long MA avg 3 mos Buy Nov 29, 2023 - 22 days
Short/Long MA avg 3 mos Buy Nov 29, 2023 - 22 days
Short MA avg 12 mos Buy Oct 25, 2023 - 36 days
Long MA avg 12 mos Buy Apr 04, 2023 - 179 days
Short/Long MA avg 12 mos Buy Apr 25, 2023 - 166 days
Pivot Short Buy Dec 29, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Eli Lilly and Company

Eli Lilly and Company Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ... LLY.MX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT